Skip to main content

Adjuvants for New and Improved Vaccines

  • Chapter
Vaccines

Part of the book series: Nato Science Series ((NSSA,volume 282))

Abstract

This series of NATO Advanced Studies Institutes is intended to bridge the widening gap between basic immunobiology and its application to vaccination. There has been a rapid expansion of knowledge about subsets of lymphocytes and accessory cells, the chemistry of immunoglobulins, cytokines, adhesion molecules and the complex interactions required for cellular and humoral responses to antigenic stimulation. A great deal of information has accumulated about the structure of bacterial, viral and other antigens. Many of these can be produced by recombinant DNA technology or peptide synthesis. Yet the practice of vaccination has changed very little during the past decade. New live virus vaccines have been introduced, including attenuated varicella-zoster virus (Oka strain of VZV, Takahashi, 1990). However, this strain, and other live viruses, can produce severe infections in immunocompromized recipients (Gershon et al., 1984). It is now recognized that immunodeficiency is commoner than formerly believed, for nutritional and other reasons (Chandra, 1991). Hence live viruses and bacteria, including vectors of antigens, may have undesirable effects in some recipients, and emphasis is now placed on optimizing the efficiency of subunit vaccines.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allison, A.C. and Byars, N.E., 1986, An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and cell-mediated immunity, J.Immun. Methods, 95:157

    Article  CAS  Google Scholar 

  • Allison, A.C. and Byars, N.E., 1992, Adjuvants for a new generation of vaccines, Can. J. Infect.Dis., 3:84B

    Google Scholar 

  • Allison, A.C. and Davies, A.J.S., 1971, Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation, Nature, 233:330

    Article  PubMed  CAS  Google Scholar 

  • Allison, A.C. and Gregoriadis, G., 1974, Liposomes as immunological adjuvants, Nature, 252:252

    Article  PubMed  CAS  Google Scholar 

  • Arden, N.H., Patricarca, P.A. and Kendal, A.P., 1986, jn: “Options for Controls of Influenza”, P.A. Kendal and P.A. Patricarca, eds., Alan R. Liss, New York

    Google Scholar 

  • Ambrose, M.W., Wyde, P.R. and Ewasishyn, M., 1993, Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats, Vaccine, 9:505

    Article  Google Scholar 

  • Alper, C.A., Krushall, M.S. and Marcus-Bagley, D., 1989, Genetic predictions of nonresponse to hepatitis B vaccine, N.Engl.J.Med., 321:708

    Article  PubMed  CAS  Google Scholar 

  • Audibert, F.M. and Lise, L.D, 1993, Adjuvants: current status, clinical perspectives and future prospects, Immunol. Today, 14:281

    Article  PubMed  CAS  Google Scholar 

  • Beasley, R.P. and Hwang, L.Y. 1984, Hepatocellular carcinoma and hepatitis B virus, Semin. Liver Dis., 4:113

    Google Scholar 

  • Beasley, R.P., Hwang, L.Y., Lee, G.C., 1983, Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immunoglobulin and hepatitis B vaccine, Lancet, ii:1099

    Article  Google Scholar 

  • Belshe, B.B., Van Wors, L.P. and Mufson, M.A., 1982, Parenteral administration of a live respiratory syncytial virus vaccine: results of a field trial, J.Inf.Dis., 145: 311

    Article  CAS  Google Scholar 

  • Bomford, R. 1989. Aluminium salts: perspectives on their use as adjuvants, in: “Immunological Adjuvants & Vaccines”, NATO ASI Series, Gregoriadis, G., Allison, A.C., Poste, G., eds., Plenum Press, London

    Google Scholar 

  • Burt, D.S., Warren, A.P. and Barnett, B.C., 1993, Antigenic variation and the T-lymphocyte repertoire for influenza hemagglutinin, in: “Viruses and the Cellular Immune Response”, D.B. Thomas, ed., Marcel Dekker, New York

    Google Scholar 

  • Byars, N.E., Allison, A.C., Harman, M.W. and Kendall, A.P., 1990, Enhancement of antibody responses to influenza B hemagglutinin by the use of a new adjuvant formulation, Vaccine8:49

    Article  PubMed  CAS  Google Scholar 

  • Byars, N.E., Fraser-Smith, E.B., Pecyk, R.A., 1994, Vaccinating guinea pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vaginal infection, Vaccine, 12:200

    Article  PubMed  CAS  Google Scholar 

  • Byars, N.E., Nakano, G., Welch, M., 1991, Improvement of hepatitis B vaccine by the use of a new adjuvant, Vaccine, 9:308

    Article  Google Scholar 

  • Campbell, M.J. Esserman, L., Byars, N.E., Allison, A.C. and Levy, R., 1989, Development of a new therapeutic approach to B-cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor, Intern.Rev.Immunol., 4:251

    Article  CAS  Google Scholar 

  • Chandra, R.K., 1991, Nutrition and immunity, in: “Clinical Immunology”, J. Brostoff, G.K. Scadding, D.K. Mole, I.M. Boitt, eds., Lipincoatt, Philadelphia

    Google Scholar 

  • Chedid, L., Parant, M.A., Audibert, F. et al.1982, Biological activity of a new synthetic muramyl peptide devoid of pyrogenicity, Infect.Immun., 35:417

    PubMed  CAS  Google Scholar 

  • Choo, Q.L., Kuo, E., Weiner, A.J. et al.1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science, 244:359

    Article  PubMed  CAS  Google Scholar 

  • Clarke, B.E., Braun, A.L., Grace, K.G. et al. 1990, Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria, J.Gen.Virol., 71:1109

    Article  PubMed  CAS  Google Scholar 

  • Dresser, D.W. and Mitchison, N.A., 1968, The mechanism of immunological paralysis, in: “Advances in Immunology”, Vol. 8, F.J. Dixon, Jr., H.G. Kunkel, eds., Academic Press, New York

    Google Scholar 

  • Ellouz, F., Adam, A., Ciorbaru, R. and Lederer, E., 1974, Minimal structural requirements for adjuvant activity of bacterial peptidoglycans, Biochem.Biophys.Res.Comm., 59:1317

    Article  PubMed  CAS  Google Scholar 

  • Epstein, M.A., Achong, B.G., eds., 1979, in. “The Epstein-Barr Virus”, Springer-Verlag, Berlin

    Google Scholar 

  • Finkelman, F.D., Holmes, J., Katona, I.M., et al. 1990, Lymphokine control of in vivoimmunoglobulin isotype selection, Ann.Rev.Immunol., 8:303

    Article  CAS  Google Scholar 

  • Francis, M.J., Hastings, G.Z., Braun, F. et al., 1991, Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot- and-mouth disease virus, Immunology, 73:249

    PubMed  CAS  Google Scholar 

  • Freund, J., 1951, The effect of paraffin oil and mycobacteria on antibody formation and sensitization, Am.J.Clin.Pathol., 21:645

    PubMed  CAS  Google Scholar 

  • Gershon, A.A., Steinberg, S.P., Gelle, L. et al.1984, Live varicella vaccine: efficacy for children with leukemia in remission, JAMA, 252:355

    Article  PubMed  CAS  Google Scholar 

  • Gilmour, J.E., Senior, J.M., Burns, N.E. et al.1989, A novel method for purification of HIV-1 p24 protein from hybrid Ty virus-like particles. (Ty-VLPS), AIDS, 3:717

    Article  PubMed  CAS  Google Scholar 

  • Hamaoka, T., Katz, D.H., Benacerraf, B. 1973. Hapten-specific antibody responses in mice II. Cooperative interactions between adoptively transferred T- and B-lymphocytes in the development of IgE response, J.Exp.Med., 138:538

    Article  PubMed  CAS  Google Scholar 

  • Hayward, A.J., Giller, R. and Levin, M., 1989, Phenotype, cytotoxic and helper functions of T-cells from varicella-zoster virus stimulated cultures of human lymphocytes, Virol. Immunol., 2:175

    Article  CAS  Google Scholar 

  • Holt, L.B., 1949, Quantitative studies in diphtheria prophylaxis: the primary response, BnL Exp.Pathol.30:289.

    CAS  Google Scholar 

  • Imoto, M., Yoshimura, H., Sakaguchi, N., Kusumoto, S. and Shiba, T., 1987, Total synthesis of Escherichia colilipid A, Tetrahedron Lett., 26:1545

    Article  Google Scholar 

  • Kaminski, M.S., Kitamura, K. Maloney, D.G., et al1986, Importance of antibody isotype in monoclonal anti-idiotype therapy of murine B-cell lymphoma. A study of hybridoma class-switch variants, J.Immunol., 136:1123

    PubMed  CAS  Google Scholar 

  • Kenney, J.S., Hughes, B.M. and Allison, A.C., 1990, Determination of antibody affinity and concentration by solution-phase microradioimmunoassay, in: “Laboratory Methods in Immunology”, H. Zola, ed., CRC Press, Boca Raton

    Google Scholar 

  • Kenney, J.S., Hughes, B.W., Masada, M.P. and Allison, A.C., 1989, Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies, J.Immunol. Methods, 121:157

    Article  PubMed  CAS  Google Scholar 

  • Kayhty, H., Eskola, J., Pettola, H. et al.1991. Antibody responses to four Haemophilus influenzaetype 6 conjugate vaccines, Amer.J.Dis.Child., 145:223

    PubMed  CAS  Google Scholar 

  • Kit, S. and Kit, M., 1991, Genetically engineered herpesvirus vaccines. Accomplishments in pigs and prospects in humans, Progr. Med. Virol., 38:128

    CAS  Google Scholar 

  • Klaus, G.G., Humphrey, J.H., Kunkl, A. and Dongworth, D.W., 1980, The follicular dendritic cell: Its role in antigen presentation and in the generation of immunological memory, Immunol.Rev., 53:3

    Article  PubMed  CAS  Google Scholar 

  • Knight, S.C., Macatonia, S.E., Roberts, M.S. et al.1993. Dendritic cells and antigen presentation, in: “Viruses and the Cellular Immune Response”, D.B. Thomas, ed., Marcel Dekker, New York

    Google Scholar 

  • Kwak, L.W., Campbell, M.J., Czerwinkski, D.K. et al. 1992, Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors, N.Engl.Med., 327:1209

    Article  CAS  Google Scholar 

  • Lifely, M.R., 1993, Polysaccharide vaccines, in: “New Generation Vaccines”, G. Gregoriadis, A.C. Allison, G. Poste, eds., Plenum Press, New York

    Google Scholar 

  • McKay, P., Lees, J., and Murray, K., 1981, The conversion of hepatitis B core antigen synthesized in E. coliinto E antigen, J.Med.Virol., 8:237

    Article  Google Scholar 

  • McKercher, P.D., 1986, Oil adjuvants: their use in veterinary biologies, in: “Advances in Carriers and Adjuvants for Veterinary Biologies”, R.M. Nervig, P. Gough, M.L. Kaeberle, eds., Iowa State University Press, Ames, Iowa

    Google Scholar 

  • Milich, D.R. and Chisari, F.V., 1982., Genetic restriction of the immune response to hepatitis B surface antigen (HBsAg). I. Restriction of the murine humoral response to the a and d determinants of HBsAg, J.Immunol., 129:320

    PubMed  CAS  Google Scholar 

  • Morgan, A.J., Allison, A.C., Finerty, S. et al.1989, Validation of a first generation Epstein-Barr virus vaccine preparation suitable for human use, J.Med.ViroL, 29:74

    Article  PubMed  CAS  Google Scholar 

  • Morris, A.G., Lin, Y.-L. and Askonas, B.A., 1982, Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target, Nature, 95:150

    Article  Google Scholar 

  • Murray, J.L., Kleinerman, E.S., Cunningham, J.E. et al. 1989, Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients, J.Clin.Oncol., 7:1915

    PubMed  CAS  Google Scholar 

  • Murray, K., Bruce, S.A., Hinnen, P. et al.1984, Hepatitis B virus antigens made in microbial cells immunize against viral infection, EMBO J., 3:645

    PubMed  CAS  Google Scholar 

  • Murray, R., Cohen, P. and Hardegree, M.C., 1972, Mineral oil adjuvants: biological and chemical studies, Ann.Allerg., 30:146

    PubMed  CAS  Google Scholar 

  • Okazaki, W., Purchase, H.G. and Burmester, P.R., 1970, Protection against Marek’s disease by vaccination with a herpesvirus of turkeys, Avian Pis., 14:213

    Google Scholar 

  • Persson, G.R., Engel, P., Whitney, C. et al. 1994, Immunization against Porphyromonas gingivalisinhibits progression of experimental periodontitis in nonhuman primates, Infect.Immun., 62:1026

    Google Scholar 

  • Reichmann, L., Clark, M., Waldmann, H. and Winter, G., 1988, Reshaping human antibodies for therapy, Nature, 332:323

    Article  Google Scholar 

  • Ribi, E., Ulrich, J.T. and Masihi, K.N., 1993, Immunopotentiating activities of monophosphoryl lipid A, in: “Immunopharmacology of Infectious Piseases: Vaccine Adjuvants and Modulation of Non-specific Resistance”, J.A. Majde, ed., Alan R. Liss, New York

    Google Scholar 

  • Ron, Y. and Sprent, J., 1987, T-cell priming in vitro: A major role for B-cells in presenting antigen to T-cells in lymph nodes, J.ImmunoL, 138:2848.

    PubMed  CAS  Google Scholar 

  • Rossmann, M.G., Arnold, E., Erickson, J.W. et al.1985, Structure of a human common cold virus and functional relationship to other picornaviruses, Nature, 317:145

    Article  PubMed  CAS  Google Scholar 

  • Scheuermann, R.H., Racila, E., Tucker, T. et al.1994, Lintyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells, Proc.Natl.Acad.Sci.USA, 91:4098

    Article  Google Scholar 

  • Scolnick, E.M., McLean, A.A., West, P.J. et al. 1984, Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant PNA, JAMA, 251:2812

    Article  PubMed  CAS  Google Scholar 

  • Spitznagel, J.K. and Allison, A.C., 1970, Mode of action of adjuvants: effects on antibody responses to macrophage-associated bovine serum albumin, J.Immunol., 104:128

    PubMed  CAS  Google Scholar 

  • Steinman, R.M ., 1991, The dendritic cell system and its role in immunogenicity, Ann.Rev. Immunol., 7:91.

    Google Scholar 

  • Szakal, A.K., Kosco, M.H. and Tew, J.G., 1989, Microanatomy of lymphoid tissue during humoral immune responses: Structure function relationships, Ann.Rev.Immunol., 7:91

    Article  CAS  Google Scholar 

  • Takahashi, H., Takeshita, T., Morein, B. et al.1990, Induction of CP8+ cytotoxic T-cells by immunization with purified HIV-1 envelope protein in ISCOMS, Nature, 344:873

    Article  PubMed  CAS  Google Scholar 

  • Tam, J.P., 1988, Synthetic peptide vaccine design: synthesis and properties of a high density multiple peptide antigenic system, Proc.Natl.Acad.Sci.USA, 85:5409

    Article  PubMed  CAS  Google Scholar 

  • Thomas, D.B., Burt, D.S., Barnett, B.C. et al. 1989, B- and T-cell recognition of influenza virus hemagglutinin, Cold Spr. Harbor Symp.Quant.Biol., 54:487

    Google Scholar 

  • Tsujimoto, M., Kinoshita, F., Okunaga, T., Kotani, T., Kusumoto, S., Yamamoto, K. and Shiba, T., 1979, Higher immunoadjuvant activities of N-acetyl-p-P-glucosaminyl-(l- 4)-N-aeetylmuramyl-L-alanyl-P-iso glutamine in comparison with N- acetamylmuramyl-L-alanyl-P-isoglytamine, Microbiol.Immunol., 23:933

    PubMed  CAS  Google Scholar 

  • Unanue, E.R., Askonas, B.A. and Allison, A.C., 1969, A role of macrophages in the stimulation of immune responses by adjuvants, J.Immunol., 103:71

    PubMed  CAS  Google Scholar 

  • Unkeless, J.C., Scigliano, E. and Freedman, V.H., 1988, Structure and function of human and murine receptors for IgG, Ann.Rev.Immunol., 6:251

    Article  CAS  Google Scholar 

  • Valenzuela, P., Medina, A., Rutter, W.J. et al.1982, Synthesis and assembly of hepatitis B virus surface antigen in yeast, Nature, 298:347

    Article  PubMed  CAS  Google Scholar 

  • Van Regenmortel, M.H.V., 1990, Structure of viral B-cell epitopes, Res.Microbiol., 141:747

    Article  PubMed  Google Scholar 

  • Van Rooijen, N . 1992. Macrophages as accessory cells in the in vivo humoral immune response: from processing of particulate antigens to regulation by suppression, Seniin. Immunol., 4:237

    Google Scholar 

  • Vijay, H.M., Lavregne, G., Huang, H. and Bernstein, I.L., 1979, Preferential synthesis of IgE reaginic antibodies in rats immunized with alum adsorbed antigens, Int.Arch.Allergy Appl.Immunol., 59:227

    Article  PubMed  CAS  Google Scholar 

  • Virelizier, J.L., Allison, A.C. and Schild, J.S., 1979, Immune response to influenza virus in the mouse, Brit. Med. Bull., 35:65

    PubMed  CAS  Google Scholar 

  • Vitetta, E.S. and Uhr, J.W. 1994, Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy, Cancer Res, in press

    Google Scholar 

  • Walker, B.D., Flexner, C., Paradis, T.J. et al.1988, HIV-1 reverse transcriptase is a target for cytotoxic T-lymphocytes in infected individuals, Science, 240:64

    Article  PubMed  CAS  Google Scholar 

  • Walker, M.E., Smuzness, W., Stevens, C. et al.1981, Genetics of anti-HBs responsiveness. HLA-DR7 and nonresponsiveness to hepatitis vaccinations, Proc.Am.Assoc.Blood Banks, 321:708

    Google Scholar 

  • Waters, R.V., Terrell, T.G. and Jones, G.H., 1982, Uveitis induction in the rabbit by muramyl dipeptides, Infect.Immun., 51:816

    Google Scholar 

  • White, R.G. 1976, The adjuvant effect of microbial products on the immune response, Ann.Rev.Microbial., 30:579

    Google Scholar 

  • Wilson, I.A. and Cox, N.J., 1990, Structural basis of immune recognition of influenza virus hemmagglutinin, Annu.Rev.Immunol., 8:737

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Plenum Press, New York

About this chapter

Cite this chapter

Allison, A.C. (1995). Adjuvants for New and Improved Vaccines. In: Gregoriadis, G., McCormack, B., Allison, A.C. (eds) Vaccines. Nato Science Series, vol 282. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0357-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0357-2_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-8014-6

  • Online ISBN: 978-1-4613-0357-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics